Overview
Daniel Kehl practices practicing medicine in Pecs, Hungary.
His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS).
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Daniel Kehl
Is Daniel Kehl a top-rated expert for Monoclonal Gammopathy of Undetermined Significance (MGUS)?
MediFind is an objective health platform that identifies experts based on real-world data. Daniel Kehl is classified as an Experienced expert for Monoclonal Gammopathy of Undetermined Significance (MGUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Daniel Kehl participate in research or clinical trials?
Yes. Daniel Kehl has published 15 articles and abstracts on conditions like Monoclonal Gammopathy of Undetermined Significance (MGUS). You can view a list of Daniel Kehl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)